https://www.selleckchem.com/products/erastin.html
To compare robotic mastectomy with open classical technique outcomes in breast cancer patients. As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages and dangers. In a phase III, open label, single center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of roboti
Like
Comment
Share
